As of April 19, 2025, Passage Bio (PASG) has a market cap of $20.509 million USD. According to our data, Passage Bio is ranked No.8549 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $20.51 M |
-41.44%
|
Dec 31, 2024 | $35.02 M |
-43.86%
|
Dec 29, 2023 | $62.38 M |
-26.81%
|
Dec 30, 2022 | $85.24 M |
-78.27%
|
Dec 31, 2021 | $0.39 B |
-75.17%
|
Dec 31, 2020 | $1.58 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.989 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.30 B |
0.000 M
|
![]() USA
|
![]() Adverum Biotechnologies
ADVM
|
$61.21 M |
0.000 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.67 B |
-0.000 M
|
![]() USA
|
![]() uniQure
QURE
|
$0.70 B |
-0.000 M
|
![]() Netherlands
|
![]() Voyager Therapeutics
VYGR
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() MeiraGTx
MGTX
|
$0.43 B |
-0.000 M
|
![]() USA
|
![]() Solid Biosciences
SLDB
|
$0.20 B |
0.000 M
|
![]() USA
|
![]() Generation Bio
GBIO
|
$26.27 M |
0.007 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.70 B |
0.000 M
|
![]() USA
|
Market Cap | = | PASG Stock Price | * | PASG Shares Outstanding |
= | $0.33 | * | 62.15 M | |
= | $20.51 M |